Stage III and IV Melanoma
1 clinical trials · Condition
◉ Watch Stage III and IV Melanoma
| Record | Firm | Date |
|---|---|---|
| Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma. (NCT00688090) | Mannkind Corporation | 2008-06-01 |
Track Stage III and IV Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.